Carrageenan polysaccharides and oligosaccharides with distinct immunomodulatory activities in murine microglia BV-2 cells

Autor: Wang Guangqiang, Xiong Zhiqiang, Syuan-Yu Lin, Kee-Ching G. Jeng, Lianzhong Ai, Yung-Chin Chung, Phoency F.-H. Lai
Rok vydání: 2018
Předmět:
Zdroj: International Journal of Biological Macromolecules. 120:633-640
ISSN: 0141-8130
DOI: 10.1016/j.ijbiomac.2018.08.151
Popis: This study was to investigate the anti-inflammatory activities in vitro of various carrageenans ( Car ) fractions (κ-, ι-, and λ-types) with well characterized molecular properties, using murine microglia BV-2 cell line treated with lipopolysaccharide (LPS) as model. It is indicated that pretreatments with the oligosaccharide fractions from κ- or ι-carrageenan acid hydrolysates ( κ- and ι-CarAOS , respectively) at 125–500 μg/mL significantly and dose-dependently decreased the levels of tumor necrosis factor α (TNF-α) secreted from LPS-treated BV-2 cells, showing promisingly anti-inflammatory effects. Differently, pretreatments of most of polymeric carrageenans at 250–500 μg/mL significantly increased the TNF-α level, implying the co-inflammatory effects with LPS. The co-inflammatory effectiveness of pure carrageenans at 125 μg/mL was notable for λ-Car , followed by ι-Car , and insignificantly for κ-Car . Generally, cytokine TNF-α was a more sensitive biomarker to the presence of carrageenans than was the IL-6. The TNF-α level varied greatly at a low carrageenan concentration (125 μg/mL) and high polymer percentage ( e.g. purified κ- and ι-Car ). Conclusively, the anti-inflammatory effects on LPS-treated BV-2 cells could be attenuated by pretreatments with κ- and ι-CarAOS at 125–500 μg/mL.
Databáze: OpenAIRE